Key result
IVC filter removal is linked to ~71% lower VTE recurrence versus retention.
Why the study?
Although guidelines recommend removing retrievable IVC filters once anticoagulation is feasible, many remain in place, and the long-term consequences of retention remain unclear.
Does IVC filter removal reduce VTE recurrence, major bleeding, or mortality in patients with acute VTE compared to filter retention?
Cohort (n=1,186)
Yes
Does IVC filter removal reduce VTE recurrence, major bleeding, or mortality in patients with acute VTE compared to filter retention?
Answers are grounded in this paper and cite their sources.
In patients with acute VTE, timely retrieval of IVC filters is associated with significantly lower risks of VTE recurrence and all-cause mortality compared to filter retention.
Background Retrievable inferior vena cava (IVC) filters are used in patients with acute venous thromboembolism (VTE) who have temporary contraindications to anticoagulation. Although guidelines recommend removing filters once anticoagulation is feasible, many filters remain in place. Long-term consequences of retention remain unclear. Aims To compare clinical outcomes in patients with VTE and retrievable IVC filters, according to filter status and anticoagulation use. Methods We analyzed patients from the international RIETE registry who received retrievable IVC filters. Outcomes from day 90 onward were stratified by filter status (removed vs retained) and anticoagulation (on vs off). Primary endpoints included VTE recurrence, major bleeding, and all-cause mortality. Filter-related complications were assessed. Results Among 1,186 patients (mean age 62 years, 51% male), 51.9% had filters removed by day 90. Patients with retained filters more often had active cancer and received longer anticoagulation, primarily low-molecular-weight heparin. VTE recurrence was higher with retained filters (4.5–6.5 vs 1.2–1.3 events per 100 patient-years), mainly as DVT; removal was associated with lower risk (aIRR 0.29 [0.15–0.54]). All-cause mortality was higher in patients with retained filters (7.3–17.7 vs 3.8–4.5); removal aOR 0.53 [0.34–0.81]. Major bleeding was infrequent, with higher rates in patients with retained filters off anticoagulation. Filter-related complications were rare and did not differ significantly between groups after adjustment. Conclusion In this large registry, retained IVC filters were associated with higher risk of VTE recurrence, even with extended anticoagulation. Findings support structured follow-up and timely filter retrieval.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2026) conducted a cohort in Acute venous thromboembolism (VTE) (n=1,186). IVC filter removal vs. Retained IVC filter was evaluated on VTE recurrence (aIRR 0.29, 95% CI 0.15-0.54). IVC filter removal was associated with a 71% lower adjusted risk of VTE recurrence and a 47% lower adjusted risk of all-cause mortality compared to filter retention.
Synapse has enriched 10 related papers. Consider them for comparative context: